{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:39:19Z","timestamp":1787942359640,"version":"build-2784847793"},"reference-count":36,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Secreted phospholipase B is a proven virulence factor for the pathogenic fungus\n            <jats:italic>Cryptococcus neoformans<\/jats:italic>\n            and exhibits three phospholipase activities in the one protein. These are phospholipase B (PLB), lysophospholipase (LPL), and lysophospholipase transacylase (LPTA). Our aim was to investigate the feasibility of using this enzyme as a target for antifungal therapy. We determined in\n            <jats:italic>C. neoformans<\/jats:italic>\n            var.\n            <jats:italic>grubii<\/jats:italic>\n            strain H99 that 82% of PLB activity was secreted but that 64% of LPL activity and 70% of LPTA activity were cell associated. Cell-associated activities (cytosolic and membrane) were further characterized, since it is likely that any fungicidal effect would depend on inhibition of these enzymes. Four commercially available compounds with structural similarities to phospholipid substrates were tested as inhibitors. These were alexidine dihydrochloride (compound A), dioctadecyldimethylammonium bromide (compound O), 1,12 bis-(tributylphosphonium)dodecane dibromide (compound P), and decamethonium dibromide (compound D). The best phospholipase inhibitors (compounds A and P) were also the most potent antifungal agents by the standard broth microdilution test. Compound A was highly selective for secreted and cell-associated PLB activities and showed no inhibition of mammalian phospholipase\n            <jats:italic>A<\/jats:italic>\n            <jats:sub>2<\/jats:sub>\n            at 0.25 \u03bcM. Compound O, which was specific for secretory and cytosolic LPL and LPTA and membrane-associated PLB, was not antifungal. We conclude that inhibitors of cryptococcal phospholipases can be selective for fungal enzymes and intrinsically antifungal. They also provide tools for assessing the relative importance of the various enzyme activities in virulence. Our results enable further rational structure-function studies to validate the use of phospholipases as antifungal targets.\n          <\/jats:p>","DOI":"10.1128\/aac.48.5.1561-1569.2004","type":"journal-article","created":{"date-parts":[[2004,4,22]],"date-time":"2004-04-22T19:58:16Z","timestamp":1082663896000},"page":"1561-1569","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":60,"title":["In Vitro Antifungal Activities of Inhibitors of Phospholipases from the Fungal Pathogen\n            <i>Cryptococcus neoformans<\/i>"],"prefix":"10.1128","volume":"48","author":[{"given":"Ranjini","family":"Ganendren","sequence":"first","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Widmer","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatsala","family":"Singhal","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabel","family":"Wilson","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Sorrell","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Wright","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology, University of Sydney at Westmead, and Department of Infectious Diseases, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.3.751-755.1996"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1139\/o59-099"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1093-3263(02)00141-9","volume":"21","year":"2002","unstructured":"Bremner, J. B., K. Castle, R. Griffith, P. A. Keller, and D. D. Ridley. 2002. Mining the chemical abstracts database with pharmacophore-based queries. J. Mol. Graphics Model21:185-194.","journal-title":"J. Mol. Graphics Model"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/jm9911027","volume":"43","year":"2000","unstructured":"Calas, M., M. L. Ancelin, G. Cordina, P. Portefaix, G. Piquet, V. Vidal-Sailhan, and H. Vial. 2000. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts. J. Med. Chem.43:505-516.","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.2.405-411.1997"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.2.414"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3470431"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909213211205"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1021\/jm00206a024","volume":"21","year":"1978","unstructured":"Coburn, R. A., P. J. Baker, R. T. Evans, R. J. Genco, and S. L. Fischman. 1978. In vitro antiplaque properties of a series of alkyl bis(biguanides). J. Med. Chem.21:828-829.","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(03)00740-6"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2001.02236.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/107175402753413136","volume":"9","year":"2002","unstructured":"Dass, C. R., T. L. Walker, and M. A. Burton. 2002. Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficacy. Drug Deliv.9:11-18.","journal-title":"Drug Deliv."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0170274"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0005-2760(90)90111-A","volume":"1043","year":"1990","unstructured":"Dijkman, R., N. Dekker, and G. H. de Haas. 1990. Competitive inhibition of lipolytic enzymes. II. Preparation of \u201cmonoacylamino\u201d phospholipids. Biochim. Biophys. Acta1043:67-74.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5391.1126"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.11.2881-2886.1992"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0005-2760(97)00163-X","volume":"1390","year":"1998","unstructured":"Gilbert, A., and R. Bittman. 1998. The inhibition of cell signalling pathways by antitumor ether lipids. Biochim. Biophys. Acta1390:85-102.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-5-973"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1054-3589(08)61011-X","volume":"32","year":"1995","unstructured":"Glaser, K. B. 1995. Regulation of phospholipase A2 enzymes: selective inhibitors and their pharmacological potential. Adv. Pharmacol.32:31-66.","journal-title":"Adv. Pharmacol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1439-0507.1995.tb00404.x","volume":"38","year":"1995","unstructured":"Hanel, H., R. Kirsch, H.-L. Schmidts, and H. Kottmann. 1995. New systematically active antimycotics from the beta-blocker category. Mycosis38:251-264.","journal-title":"Mycosis"},{"key":"e_1_3_2_22_2","first-page":"285","volume":"5","year":"2002","unstructured":"Himmelreich, U., C. Allen, S. Dowd, R. Malik, B. P. Shehan, C. Mountford, and T. C. Sorrell. 2002. Identification of metabolites of importance in pathogenesis of pulmonary cryptococcoma using nuclear magnetic resonance spectroscopy. Microbes Infect.5:285-290.","journal-title":"Microbes Infect."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0005-2760(98)00100-3","volume":"1394","year":"1998","unstructured":"Kang, J.-H., J.-H. Lee, J.-H. Park, S.-H. Huh, and I.-S. Kong. 1998. Cloning and identification of a phospholipase gene from Vibrio mimicus. Biochim. Biophys. Acta1394:85-89.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1021\/jo990739v","volume":"64","year":"1999","unstructured":"Kazi, A. B., S. Shidmand, and J. Hajdu. 1999. Stereospecific synthesis of functionalized ether phospholipids. J. Org. Chem.64:9337-9347.","journal-title":"J. Org. Chem."},{"key":"e_1_3_2_25_2","unstructured":"Kwon-Chung K. J. and J. E. Bennett. 1992. Cryptococcosis p. 397-446. In Medical mycology 16th ed. Lea & Febiger Philadelphia Pa."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0924-8579(02)00271-6","volume":"21","year":"2003","unstructured":"Massi, L., F. Guittard, S. Geribaldi, R. Levy, and Y. Duccini. 2003. Antimicrobial properties of highly fluorinated bis-ammonium salts. Int. J. Antimicrob. Agents21:20-26.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_27_2","unstructured":"Michelson M. and E. Zaimal. 1973. Acetylcholine an approach to the molecular mechanism of action. Pergamon Press Oxford United Kingdom."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(95)00072-K"},{"key":"e_1_3_2_29_2","unstructured":"National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution susceptibility testing of yeast: proposed standard. NCCLS document M27-P. National Committee for Clinical Laboratory Standards Villanova Pa."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.3.1538-1547.2003"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02262471","volume":"32","year":"1991","unstructured":"Ohki, A., J. Okamoto, K. Naka, and S. Maeda. 1991. Ion-pair chromatography of a dianionic species dionium reagent. Chromatographia32:73-78.","journal-title":"Chromatographia"},{"key":"e_1_3_2_32_2","unstructured":"Ridley D. D. 2002. Information retrieval: SciFinder and SciFinder Scholar. John Wiley & Sons Inc. New York N.Y."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/IAI.72.4.2229-2239.2004","volume":"72","unstructured":"Santangelo, R., H. Zoellner, T. Sorrell, C. Wilson, C. Donald, J. Djordjevic, Y. Shounan, and L. Wright. 2004. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect. Immun.72:2229-2239.","journal-title":"Infect. Immun."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-48-8-731"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(00)00113-X"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(02)00024-2"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2307\/3283384","volume":"79","year":"1993","unstructured":"Zidovetzki, R., I. W. Sherman, and L. O'Brian. 1993. Inhibition of Plasmodium falciparum phospholipase A2 by chloroquine, quinine and arteether. J. Parasitol.79:565-570.","journal-title":"J. Parasitol."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.5.1561-1569.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.5.1561-1569.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:17:41Z","timestamp":1645467461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.5.1561-1569.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1128\/AAC.48.5.1561-1569.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.5.1561-1569.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"2003-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-01-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}